Impact of metabolizing enzymes on drug response of endocrine therapy in breast cancer

Author： Saladores Pilar H   Precht Jana C   Schroth Werner   Brauch Hiltrud   Schwab Matthias  

Publisher： Informa Healthcare

ISSN： 1473-7159

Source： Expert Review of Molecular Diagnostics, Vol.13, Iss.4, 2013-05, pp. : 349-365

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Endocrine Therapy of Breast Cancer

By  

Current Medicinal Chemistry, Vol. 18, Iss. 4, 2011-02 ,pp. : 513-522

Bentham Science Publishers

Access to resources Recommend Favorite

Cancer and Phase II Drug-Metabolizing Enzymes

By  

Current Drug Metabolism, Vol. 4, Iss. 1, 2003-02 ,pp. : 45-58

Bentham Science Publishers

Access to resources Recommend Favorite

Enzymes To Die For: Exploiting Nucleotide Metabolizing Enzymes for Cancer Gene Therapy

By  

Current Gene Therapy, Vol. 12, Iss. 2, 2012-04 ,pp. : 77-91

Bentham Science Publishers

Access to resources Recommend Favorite

Interplay of Breast Cancer Resistance Protein (BCRP) and Metabolizing Enzymes

By  

Current Drug Metabolism, Vol. 16, Iss. 10, 2015-12 ,pp. : 877-893

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenomics in Drug-Metabolizing Enzymes Catalyzing Anticancer Drugs for Personalized Cancer Chemotherapy

By  

Current Drug Metabolism, Vol. 8, Iss. 6, 2007-08 ,pp. : 554-562

Bentham Science Publishers

Access to resources Recommend Favorite